NCT00934323 - Dose Proportionality Study About Amaryl M Slow Release (SR) 1/500 mg | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

October 31, 2008

Primary Completion Date

November 30, 2008

Study Completion Date

April 30, 2009

Conditions

Healthy

Interventions

DRUG

Amaryl M SR 1/500 mg

single oral administration in period 1 for TR sequential group, and in period 2 for RT sequential group

DRUG

Amaryl M SR 2/500 mg

single oral administration in period 2 for TR sequential group, and in period 2 for RT sequential group

Trial Locations (1)

Seoul National University Hospital, Seoul